DV
Dividend Vision

ALLR — Allarity Therapeutics Inc

Allarity Therapeutics Inc (ALLR)

Total return is -100.0% over the past 4.6 years, 178.2 points behind SPY at 78.2%. Its deepest 1-year drawdown was 58.9%.

This is a single-stock equity holding in Allarity Therapeutics Inc, a biopharmaceutical company, rather than a diversified ETF. The fund does not currently pay distributions, making it unsuitable for income-focused investors. With minimal publicly available data on expenses and assets under management, this holding appeals primarily to investors seeking exposure to the therapeutic development sector and willing to accept the concentrated risk profile of a single-company investment.

ALLR key facts

Asset type
Stock
Asset class
Equity
Inception date
12/21/2021
Last close
$1.37
Market cap
$18,933,762
Average volume
48147.0
Beta
0.526
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.70